250 related articles for article (PubMed ID: 27198469)
21. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004448. PubMed ID: 29446825
[TBL] [Abstract][Full Text] [Related]
22. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
Wang WC; Ware RE; Miller ST; Iyer RV; Casella JF; Minniti CP; Rana S; Thornburg CD; Rogers ZR; Kalpatthi RV; Barredo JC; Brown RC; Sarnaik SA; Howard TH; Wynn LW; Kutlar A; Armstrong FD; Files BA; Goldsmith JC; Waclawiw MA; Huang X; Thompson BW;
Lancet; 2011 May; 377(9778):1663-72. PubMed ID: 21571150
[TBL] [Abstract][Full Text] [Related]
23. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD004448. PubMed ID: 32977351
[TBL] [Abstract][Full Text] [Related]
24. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.
Knight-Madden JM; Hambleton IR
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD003733. PubMed ID: 36458811
[TBL] [Abstract][Full Text] [Related]
25. Sickle-cell disease.
Rees DC; Williams TN; Gladwin MT
Lancet; 2010 Dec; 376(9757):2018-31. PubMed ID: 21131035
[TBL] [Abstract][Full Text] [Related]
26. Phytomedicines (medicines derived from plants) for sickle cell disease.
Oniyangi O; Cohall DH
Cochrane Database Syst Rev; 2015 Apr; (4):CD004448. PubMed ID: 25844571
[TBL] [Abstract][Full Text] [Related]
27. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Nagalla S; Ballas SK
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003426. PubMed ID: 30338520
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
[TBL] [Abstract][Full Text] [Related]
30. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
[TBL] [Abstract][Full Text] [Related]
31. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
Cherry MG; Greenhalgh J; Osipenko L; Venkatachalam M; Boland A; Dundar Y; Marsh K; Dickson R; Rees DC
Health Technol Assess; 2012; 16(43):1-129. PubMed ID: 23140544
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic stem cell transplantation for people with sickle cell disease.
Oringanje C; Nemecek E; Oniyangi O
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007001. PubMed ID: 32617981
[TBL] [Abstract][Full Text] [Related]
33. Hydroxyurea for sickle cell disease.
Davies S; Olujohungbe A
Cochrane Database Syst Rev; 2001; (2):CD002202. PubMed ID: 11406036
[TBL] [Abstract][Full Text] [Related]
34. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
Alhashimi D; Fedorowicz Z; Alhashimi F; Dastgiri S
Cochrane Database Syst Rev; 2010 Jan; (1):CD007843. PubMed ID: 20091653
[TBL] [Abstract][Full Text] [Related]
35. Blood transfusion for preventing stroke in people with sickle cell disease.
Riddington C; Wang W
Cochrane Database Syst Rev; 2002; (1):CD003146. PubMed ID: 11869654
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
37. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Singh PC; Ballas SK
Cochrane Database Syst Rev; 2007 Oct; (4):CD003426. PubMed ID: 17943791
[TBL] [Abstract][Full Text] [Related]
38. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
[TBL] [Abstract][Full Text] [Related]
39. Folate supplementation in people with sickle cell disease.
Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
[TBL] [Abstract][Full Text] [Related]
40. Piracetam for reducing the incidence of painful sickle cell disease crises.
Al Hajeri A; Fedorowicz Z
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006111. PubMed ID: 26869149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
